Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
134 studies found for:    "Choreatic Disorders" OR "McLeod neuroacanthocytosis syndrome" OR "Neuroacanthocytosis" OR "Chorea Acanthocytosis Syndromes"
Show Display Options
Rank Status Study
21 Recruiting Randomized, Placebo Controlled Study Of The Efficacy And Safety Of PF-02545920 In Subjects With Huntington's Disease
Condition: Huntington's Disease
Interventions: Drug: PF-02545920;   Other: Placebo
22 Terminated Study to Assess the Safety, Tolerability and Pharmacokinetic Profile of PBF-999 "After Multiple Oral Doses" in Healthy Volunteers
Condition: Huntington Disease
Interventions: Drug: PBF-999 / 160 mg;   Drug: PBF-999 / 320 mg;   Drug: Placebo
23 Not yet recruiting FuRST 2.0 Cognitive Pre-Testing
Condition: Huntington's Disease
Intervention: Behavioral: FuRST 2.0
24 Completed Caregiver Burden in Huntington's Disease
Condition: Caregiver of Huntington's Disease Patient
Intervention: Other: ZARIT Burden Interview
25 Not yet recruiting HDClarity: a Multi-site Cerebrospinal Fluid Collection Initiative to Facilitate Therapeutic Development for Huntington's Disease
Condition: Huntington's Disease
Intervention:
26 Recruiting Evaluation and Characterization of Behavioural Disorders and Dementias by the Behavioural Dysexecutive Syndrome Inventory (BDSI)
Conditions: Frontotemporal Dementia;   Huntington Disease;   Alzheimer Disease;   Semantic Dementia;   Dementia, Vascular
Intervention: Behavioral: prevalence of behavioural dysexecutive syndrome
27 Recruiting STUDY OF MOTOR SLOWING IN PARKINSON'S DISEASE BY A COMPUTERIZED MENTAL CHRONOMETRY PARADIGM
Conditions: Parkinson Disease;   Huntington Disease
Intervention: Behavioral: SRT
28 Recruiting Laughter Therapy Effects on Mood, Stress and Self-efficacy in People With Neurological Diseases.
Conditions: Alzheimer's Disease;   Amyotrophic Lateral Sclerosis;   Brain Injury;   Huntington's Disease;   Multiple Sclerosis;   Parkinson's Disease;   Stroke;   Spinal Cord Injury
Intervention: Other: Laughter Therapy
29 Not yet recruiting Safety Evaluation of Cellavita HD Administered Intravenously in Participants With Huntington's Disease
Condition: Huntington Disease
Interventions: Other: Cellavita HD lower dose;   Other: Cellavita HD intermediate dose;   Other: Cellavita HD Higher dose
30 Recruiting Dynamic Neuroimaging Biomarkers in Huntington's Disease
Condition: Brain Neuroimaging Biomarkers in Huntington Disease
Intervention:
31 Recruiting Feasibility of a Video-oculography in Patients With Huntington's Disease VOG-HD Study
Condition: Huntington Disease
Intervention: Device: Eye-tracking
32 Not yet recruiting Functional Imaging of Social Cognition in Premanifest Huntington's Disease
Condition: Huntington's Disease
Intervention: Other: functional Imaging
33 Recruiting Social Cognition in Huntington's Disease: Cognitive Study and Functional and Morphological Imaging
Condition: Huntington's Disease
Interventions: Behavioral: neuropsychological test;   Radiation: MRI
34 Recruiting Deep Brain Stimulation (DBS) of the Globus Pallidus (GP) in Huntington's Disease (HD)
Condition: Huntington Disease
Intervention: Device: ACTIVA® PC neurostimulator (Model 37601)
35 Recruiting Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IONIS-HTTRx in Patients With Early Manifest Huntington's Disease
Condition: Huntington's Disease
Interventions: Drug: IONIS HTTRx;   Drug: Placebo
36 Recruiting A Pilot Study Assessing Impulsivity in Patients With Huntington's Disease on Xenazine (Tetrabenazine)
Condition: Huntington's Disease
Intervention: Drug: Tetrabenazine
37 Recruiting Tolerability, Safety, and Activity of SRX246 in Irritable Subjects With Huntington's Disease
Conditions: Irritable Mood;   Huntington's Disease
Interventions: Drug: SRX246;   Drug: Placebo
38 Enrolling by invitation A Study Evaluating if Pridopidine is Safe, Efficacious, and Tolerable in Patients With Huntington's Disease
Condition: Huntington's Disease
Intervention: Drug: Pridopidine
39 Active, not recruiting VX15/2503 Treatment for Huntington's Disease
Condition: Huntington's Disease
Interventions: Drug: VX15/2503;   Drug: Placebo
40 Enrolling by invitation A Pilot Evaluation of Mindfulness-based Cognitive Therapy for People With Huntington's Disease
Condition: Huntington Disease
Intervention: Other: Mindfulness-based cognitive therapy

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years